Streetbeat News

Analyst Ratings

PRDO

Perdoceo Education (NASDAQ:PRDO) has been evaluated by four analysts over the past three months, all of whom have given a 'Somewhat Bullish' rating. The average 12-month price target has increased to $29.25, with a high of $30.00 and a low of $27.00. Despite revenue challenges, the company shows strong profitability and effective financial management.

Portfolio Pulse from Benzinga Insights

September 20, 2024 | 4:01 pm

HWC

Truist Securities has maintained a Hold rating on Hancock Whitney (NASDAQ:HWC) while lowering the price target from $57 to $56.

Portfolio Pulse from Benzinga Newsdesk

September 20, 2024 | 4:00 pm

HQY

HealthEquity (NASDAQ:HQY) has received mixed analyst ratings over the past three months, with a majority being somewhat bullish. The average 12-month price target is $102.5, slightly down from $103. Analysts have maintained or adjusted their ratings based on market conditions and company performance. HealthEquity shows strong financial metrics, including a 23.15% revenue growth rate and a net margin of 11.94%.

Portfolio Pulse from Benzinga Insights

September 20, 2024 | 4:00 pm

CADE

Cadence Bank (NYSE:CADE) has been the subject of recent analyst evaluations, with 11 analysts providing ratings ranging from bullish to bearish. The average 12-month price target is $34.27, reflecting a 6.03% increase from the previous target. Analysts have adjusted their ratings and price targets, indicating a positive outlook for Cadence Bank. The bank has shown strong financial performance with notable revenue growth, net margin, and return on equity, although it has a higher debt-to-equity ratio than industry averages.

Portfolio Pulse from Benzinga Insights

September 20, 2024 | 4:00 pm

GBCI

Truist Securities has maintained a Hold rating on Glacier Bancorp while raising the price target from $46 to $50.

Portfolio Pulse from Benzinga Newsdesk

September 20, 2024 | 3:59 pm

FFIN

Truist Securities has maintained a Hold rating on First Finl Bankshares (NASDAQ:FFIN) while slightly raising the price target from $39 to $40.

Portfolio Pulse from Benzinga Newsdesk

September 20, 2024 | 3:58 pm

FDX

HSBC analyst Parash Jain has downgraded FedEx from Buy to Hold, setting a price target of $300.

Portfolio Pulse from Benzinga Newsdesk

September 20, 2024 | 3:56 pm

CRBP

Wedbush analyst Robert Driscoll maintains an Outperform rating on Corbus Pharmaceuticals but lowers the price target from $85 to $51.

Portfolio Pulse from Benzinga Newsdesk

September 20, 2024 | 3:49 pm

COST

The article discusses recent options activity for Costco Wholesale (NASDAQ:COST), highlighting a bearish sentiment among financial giants. Despite this, analysts maintain positive ratings with price targets ranging from $915 to $950. The stock is currently trading at $902.97, with a slight increase of 0.25%.

Portfolio Pulse from Benzinga Insights

September 20, 2024 | 3:46 pm

CRBP

Mizuho analyst Graig Suvannavejh has reiterated an Outperform rating for Corbus Pharmaceuticals (NASDAQ:CRBP) and maintained a price target of $74.

Portfolio Pulse from Benzinga Newsdesk

September 20, 2024 | 3:43 pm